Lv1
66 积分 2025-08-12 加入
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
10小时前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
11天前
已完结
TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis
17天前
已完结
Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring
17天前
已完结
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
20天前
已完结
A review of in vitro stochastic and non-stochastic affinity maturation strategies for phage display derived monoclonal antibodies
20天前
已完结
Review of phage display: A jack-of-all-trades and master of most biomolecule display
20天前
已完结
Phage display and other peptide display technologies
20天前
已完结
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies
20天前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
20天前
已完结
皖公网安备34019202002308